| William T Mcgee, MD | |
|
759 Chestnut St, S2668, Springfield, MA 01199-1001 | |
| (413) 794-5439 | |
| (413) 794-5389 |
| Full Name | William T Mcgee |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 41 Years |
| Location | 759 Chestnut St, Springfield, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649384488 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 53623 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Overlook Hospice Services | Charlton, MA | Hospice |
| Baystate Medical Center | Springfield, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baystate Medical Practices Inc | 5991602971 | 1015 |
News Archive
Now that the Supreme Court has provided legal certainty on the recent healthcare reform law, the nation must turn its attention to affordability. While the law expands coverage to millions of Americans, a goal health plans have long supported, major provisions of the law need to be changed to avoid significant cost increases for consumers and employers.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of Nevada has granted Teva's Motion for Summary Judgment with respect to the validity of U.S. Patent No. 7,320,969. In March 2008, Duramed, now Teva Women's Health, brought suit in the District of Nevada against Watson alleging infringement of Teva's patent as a result of Watson's filing of an Abbreviated New Drug Application (ANDA) for Seasonique®.
The ultra-stable properties of the proteins that allow deep-diving whales to remain active while holding their breath for up to two hours could help Rice University biochemist John Olson and his colleagues finish a 20-year quest to create lifesaving synthetic blood for human trauma patients.
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it is presenting study results at the 46th Annual Meeting of the European Association for the Study of Diabetes being held in Stockholm, Sweden, 20 - 24 September, 2010.
A team of researchers form Russia discovered that an increase in the concentration of several substances in oral fluid can serve as the indication of caries development.
› Verified 3 days ago
| Entity Name | Baystate Medical Practices Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548205909 PECOS PAC ID: 5991602971 Enrollment ID: O20040225000080 |
News Archive
Now that the Supreme Court has provided legal certainty on the recent healthcare reform law, the nation must turn its attention to affordability. While the law expands coverage to millions of Americans, a goal health plans have long supported, major provisions of the law need to be changed to avoid significant cost increases for consumers and employers.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of Nevada has granted Teva's Motion for Summary Judgment with respect to the validity of U.S. Patent No. 7,320,969. In March 2008, Duramed, now Teva Women's Health, brought suit in the District of Nevada against Watson alleging infringement of Teva's patent as a result of Watson's filing of an Abbreviated New Drug Application (ANDA) for Seasonique®.
The ultra-stable properties of the proteins that allow deep-diving whales to remain active while holding their breath for up to two hours could help Rice University biochemist John Olson and his colleagues finish a 20-year quest to create lifesaving synthetic blood for human trauma patients.
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it is presenting study results at the 46th Annual Meeting of the European Association for the Study of Diabetes being held in Stockholm, Sweden, 20 - 24 September, 2010.
A team of researchers form Russia discovered that an increase in the concentration of several substances in oral fluid can serve as the indication of caries development.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William T Mcgee, MD 280 Chestnut St, 2nd Floor, Springfield, MA 01199-1000 Ph: (413) 794-5700 | William T Mcgee, MD 759 Chestnut St, S2668, Springfield, MA 01199-1001 Ph: (413) 794-5439 |
News Archive
Now that the Supreme Court has provided legal certainty on the recent healthcare reform law, the nation must turn its attention to affordability. While the law expands coverage to millions of Americans, a goal health plans have long supported, major provisions of the law need to be changed to avoid significant cost increases for consumers and employers.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of Nevada has granted Teva's Motion for Summary Judgment with respect to the validity of U.S. Patent No. 7,320,969. In March 2008, Duramed, now Teva Women's Health, brought suit in the District of Nevada against Watson alleging infringement of Teva's patent as a result of Watson's filing of an Abbreviated New Drug Application (ANDA) for Seasonique®.
The ultra-stable properties of the proteins that allow deep-diving whales to remain active while holding their breath for up to two hours could help Rice University biochemist John Olson and his colleagues finish a 20-year quest to create lifesaving synthetic blood for human trauma patients.
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it is presenting study results at the 46th Annual Meeting of the European Association for the Study of Diabetes being held in Stockholm, Sweden, 20 - 24 September, 2010.
A team of researchers form Russia discovered that an increase in the concentration of several substances in oral fluid can serve as the indication of caries development.
› Verified 3 days ago
Grace Makari-judson, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3350 Main Street, Springfield, MA 01107 Phone: 413-794-9338 Fax: 413-794-9754 | |
Peter Whittredge, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 2 Medical Center Dr, Suite 410, Springfield, MA 01107 Phone: 413-781-5735 Fax: 413-732-0225 | |
Dr. Marc A Goldman, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 Carew St Ste 200, Springfield, MA 01104 Phone: 413-732-4269 Fax: 413-785-4619 | |
Twara K Tarasaria, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 759 Chestnut St, Springfield, MA 01107 Phone: 413-794-6297 Fax: 413-794-1767 | |
Dr. Joan Wanda Lisak, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 780 Chestnut St, Suite 20, Springfield, MA 01107 Phone: 413-781-2200 Fax: 413-781-2202 | |
Dr. Eva Karacsonyi, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2150 Main Street, Springfield, MA 01104 Phone: 413-739-5676 Fax: 413-739-2278 | |
Dr. Sun Tien Lin, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 125 Liberty St, Suite 204, Springfield, MA 01103 Phone: 413-788-4321 Fax: 413-788-8877 |